on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Schedules Investor Webcast for Q3 2026 Financial Review
Jaguar Health, Inc. (NASDAQ:JAGX) has announced an upcoming investor webcast. The event is scheduled for November 17, 2026, at 8:30 a.m. Eastern. During the webcast, the company will discuss third-quarter financial results and provide corporate updates.
The webcast is part of Jaguar Health's regular communication strategy with investors. Participants can register online to gain access. A replay will be available in the investor relations section of Jaguar Health's website.
The company's focus includes the development of plant-derived medications for gastrointestinal diseases. Its subsidiaries, including Napo Pharmaceuticals and Magdalena Biosciences, contribute to these efforts.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news